Viewing Study NCT05226533


Ignite Creation Date: 2025-12-25 @ 3:01 AM
Ignite Modification Date: 2026-01-01 @ 2:36 AM
Study NCT ID: NCT05226533
Status: TERMINATED
Last Update Posted: 2023-02-10
First Post: 2022-02-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Clinical Trials to Assess Safety and Efficacy of DWRX2003 Combination With Remdesivir in Moderate to Severe COVID-19 Patients.
Sponsor: Daewoong Pharmaceutical Co. LTD.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-03-31
Start Date Type: ACTUAL
Primary Completion Date: 2022-12-16
Primary Completion Date Type: ACTUAL
Completion Date: 2022-12-21
Completion Date Type: ACTUAL
First Submit Date: 2022-02-04
First Submit QC Date: None
Study First Post Date: 2022-02-07
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-02-08
Last Update Post Date: 2023-02-10
Last Update Post Date Type: ACTUAL